Skip to main content
. Author manuscript; available in PMC: 2019 Jul 14.
Published in final edited form as: Oncogene. 2019 Jan 14;38(18):3402–3414. doi: 10.1038/s41388-018-0672-7

Figure 8:

Figure 8:

Model of TβRIII-SS function. TβRIII-SS induces epithelial-to-mesenchymal transition. TβRIII-SS (EMT) then decreases migration and invasion, potentially through decreased adhesion. TβRIII-SS also increases gemcitabine resistance, decreases tumorigenicity but increases tumor growth rate, potentially through inhibiting canonical TGF-β signaling and promoting non-canonical TGF-β signaling.